Page 27 - Human Umbilical Cord Mesenchymal Stem Cells
P. 27

MSCS FOR CHRONIC WOUND TREATMENTS                                                              557


             CD40, and CD86) and, thus, lack significant immunogenici-  have been observed at the skin wound sites, 54,55  and notably,
             ty 36,37 ; (ii) they regulate the inflammation of injured or dis-  they secreted bioactive factors to recruit other repair cells
             eased tissues toward tissue regeneration 38,39 ; (iii) they produce  from the host animals. 56–58  A plethora of chemokines, growth
             a variety of bioactive factors to support the normal function of  factors, and receptors was involved in the recruitment of
             resident cells in hostile microenvironments. 40–42  MSCs. 59–62
               A great deal of inherent similarities have been identified
             among MSCs isolated from different tissue origins, such as  Cell differentiation
             core cell markers, conserved expression of genes, cytokines,
             and growth factors; however, there are subtle differences  As observed in the fate tracing of transplanted MSCs, a
             that should be taken into consideration when developing  small portion of cells can differentiate into skin cells at the
                                                                         7,63–72
             MSC-based therapy. 43,44  For instance, the proliferation and  wound sites.  For instance, in a mouse excisional skin
             differentiation of MSCs varied obviously among different  wound model, Wu et al. reported that topically adminis-
             tissues. 45                                       trated MSCs differentiated into keratinocytes and formed
                                                                                               63
                                                               glandular structures at the wound bed.  In other studies,
                                                               MSCs were found to differentiate into endothelial cells 8,68–71
             The Critical Roles of MSCs in Wound Healing                         7,72
                                                               and skin appendages.  After allogenic bone marrow re-
               The mechanisms of MSC-based wound therapy have not  constitution, donor-derived BM-MSCs have been observed to
             been fully delineated, yet, two mechanisms are generally  participate in the hair regeneration of host mice. 7
             postulated: (i) direct differentiation into skin cells and (ii)
             the secretion of trophic factors (Fig. 1). Considering the  Immunomodulation
    Downloaded by 23.227.145.6 from www.liebertpub.com at 08/10/21. For personal use only.
             poor engraftment of MSCs at chronic wounds, it is widely
             believed that the therapeutic effects depend predominantly  In chronic wounds, high levels of inflammatory factors
             on their paracrine actions by which MSCs secret a multitude  prevent wound healing. Due to their immunomodulation
             of soluble factors (Table 1), such as growth factors, immune  activities, MSCs are helpful in overcoming the hyperin-
             factors, chemokines, and exosomes, to enhance the survival,  flammation of chronic wounds, which promotes the transi-
             recruitment, and function of wound repair cells. This finding  tion of wound healing from the inflammatory phase to the
             is supported by a growing body of evidence: for instance,  proliferative phase. MSCs not only coordinate the actions of
                                                                              73,74
             MSC-conditioned medium has a potent healing effect on  inflammatory cells  but also inhibit the deleterious ef-
                                                                                         74–76
             skin wounds. 46–49                                fects of inflammatory cytokines.
                                                                 When activated by inflammatory factors, MSCs become
                                                               potently immunosuppressive, secreting soluble mediators (e.g.,
             Cell recruitment
                                                               NO and prostaglandin E2) to decrease excessive immune re-
                                                                     76–78
               MSCs can home to injured skin and participate in wound  actions.  They suppress T cell proliferation, B lymphocyte
             healing. In the mouse chimeric bone marrow transplantation  differentiation, and natural killer cell functions; also, they
             model, several groups reported the migration of bone marrow  modulate macrophage phenotypes, disturb dendritic cell func-
             cells into skin wounds. 50–53  Likewise, after systemic admin-  tions, 78–81  and decrease the secretionofproinflammatory cy-
             istration, exogenous bone marrow-derived MSCs (BM-MSCs)  tokines. 73,74,76  Notably, the immunomodulation of MSCs is




























             FIG. 1.  Transplantation of MSCs enhance chronic wound healing through multiple repair mechanisms. bFGF, basic
             fibroblast growth factor; EGF, epidermal growth factor; IL-10, interleukin-10; MSCs, mesenchymal stem cells; SDF-1,
             stromal cell-derived factor-1; TGF-b1, transforming growth factor-b1; VEGF, vascular endothelial growth factor. Color
             images are available online.
   22   23   24   25   26   27   28   29   30   31   32